Shenzhen Neptunus Interlong Bio-technique Company Limited

SEHK:8329 Stock Report

Market Cap: HK$224.9m

Shenzhen Neptunus Interlong Bio-technique Balance Sheet Health

Financial Health criteria checks 5/6

Shenzhen Neptunus Interlong Bio-technique has a total shareholder equity of CN¥1.1B and total debt of CN¥89.4M, which brings its debt-to-equity ratio to 8.5%. Its total assets and total liabilities are CN¥1.4B and CN¥367.6M respectively. Shenzhen Neptunus Interlong Bio-technique's EBIT is CN¥60.6M making its interest coverage ratio 157. It has cash and short-term investments of CN¥391.9M.

Key information

8.5%

Debt to equity ratio

CN¥89.40m

Debt

Interest coverage ratio157x
CashCN¥391.95m
EquityCN¥1.06b
Total liabilitiesCN¥367.57m
Total assetsCN¥1.43b

Recent financial health updates

Recent updates

Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

Sep 05
Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

Apr 19
We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Oct 03
These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

Mar 29
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

Sep 28
We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Aug 18
A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Jun 06
Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Dec 15
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Dec 29
Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Nov 24
Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Financial Position Analysis

Short Term Liabilities: 8329's short term assets (CN¥930.7M) exceed its short term liabilities (CN¥330.8M).

Long Term Liabilities: 8329's short term assets (CN¥930.7M) exceed its long term liabilities (CN¥36.8M).


Debt to Equity History and Analysis

Debt Level: 8329 has more cash than its total debt.

Reducing Debt: 8329's debt to equity ratio has increased from 4.8% to 8.5% over the past 5 years.

Debt Coverage: 8329's debt is well covered by operating cash flow (142.3%).

Interest Coverage: 8329's interest payments on its debt are well covered by EBIT (157x coverage).


Balance Sheet


Discover healthy companies